Paclitaxel News and Research

RSS
Paclitaxel is a drug used to treat breast cancer, ovarian cancer, and AIDS-related Kaposi sarcoma. It is also used together with another drug to treat non-small cell lung cancer. Paclitaxel is also being studied in the treatment of other types of cancer. It blocks cell growth by stopping cell division and may kill cancer cells. It is a type of antimitotic agent. Also called Taxol.

The Paclitaxel compound is extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity. Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division. This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). Check for active clinical trials or closed clinical trials using this agent.
Chemotherapy regimen more effective and more toxic in Japanese patients than in American patients

Chemotherapy regimen more effective and more toxic in Japanese patients than in American patients

Herceptin shows real promise in treatment of HER-2 positive breast disease

Herceptin shows real promise in treatment of HER-2 positive breast disease

Gemcitabine may help breast cancer patients with advanced disease live longer

Gemcitabine may help breast cancer patients with advanced disease live longer